Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Clinical Trial Conducted Via Telepsychiatry of Oral Thiamine for the Treatment of Depression In Youth

NCT07793071 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT07793071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07793071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Clinical Trial Conducted Via Telepsychiatry of Oral Thiamine for the Treatment of Depression In Youth
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
January 1, 2029
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder (mdd), pediatrics, thiamine, thiamine diphosphate (tdp), vitamin b1